Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
Insider trades, last 90 days
1 buy · 0 sells
- Bought $2.03K
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
27
- +2 vs. Q1 2026
- Total value $2.73M
Superinvestors holding SER
0
- None of the superinvestors held SER at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by SER insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 202612:05 PM ET | Jul 7, 2026 | Brannan Stephen K.Director | PPurchaseCommon Stock | +1K | $2.03 | +$2.03K | 1K | New position | SEC |
| Jun 22, 2026 | May 22, 2026 | Venkatesan JayDirector | PPurchaseCommon Stock | +589 | $1.78 | +$1.05K | 589 | New position | SEC |
| Jun 15, 2026 | Jun 11 – Jun 12, 2026 | WILSON KAREN JDirector | PPurchaseCommon Stock | +10.1K | $1.7599 | +$17.78K | 10.1K | New position | SEC |
| May 26, 2026 | May 21 – May 22, 2026 | WILSON KAREN JDirector | PPurchaseCommon Stock | +20K | $1.85 | +$37K | 20K | New position | SEC |
| May 22, 2026 | May 19, 2026 | Marshall Richard PeterDirector | PPurchaseCommon Stock | +12.18K | $1.65 | +$20.1K | 12.18K | New position | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in SER at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sio Capital Management, LLC | 1,000,000 | $1.94M | 0.33% | 00.0% | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | 162,198 | $314.66K | 0.00% | +3,062+1.9% | Added |
| Warren Averett Asset Management, LLC | 67,492 | $130.93K | 0.00% | 00.0% | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | 51,007 | $98.96K | 0.00% | −13,966−21.5% | Reduced |
| Keel Point, LLC | 21,508 | $41.73K | 0.00% | 00.0% | Unchanged |